Sub-chronic administration of AM251, CB1 receptor antagonist, within the nucleus accumbens induced sensitization to morphine in the rat

Neuroscience Letters

Volumn 467, Issue 1, 2009, Pages 43-47

  Haghparast, Abbas ^a   Azizi, Pegah ^a,b   Hassanpour Ezatti, Majid ^b   Khorrami, Hossein ^a   Naderi, Nima ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

AM251; CB1 receptor; Conditioned place preference; Morphine; Nucleus accumbens; Rat

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; DIMETHYL SULFOXIDE; MORPHINE SULFATE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DENDRITIC SPINE; DRUG SENSITIZATION; EXPERIMENTAL MODEL; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SYNAPTIC INHIBITION; WISTAR RAT;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; CATHETERIZATION; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MORPHINE; NUCLEUS ACCUMBENS; PIPERIDINES; PYRAZOLES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SPACE PERCEPTION; TIME FACTORS;

EID: 70350416444     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.09.062     Document Type: Article

References (34)

1. Azizi P., Haghparast A., and Hassanpour-Ezatti M. Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats. Behav. Brain Res. (2008)
2. Cardinal R.N., Pennicott D.R., Sugathapala C.L., Robbins T.W., and Everitt B.J. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292 (2001) 2499-2501
3. Castane A., Valjent E., Ledent C., Parmentier M., Maldonado R., and Valverde O. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 43 (2002) 857-867
4. Cichewisez D.L., Haller V.L., and Welch S.P. Changes in opioid and cannabinoid receptor protein following short-term combination treatment with D9-tetrahydrocannabinol and morphine. J. Pharmacol. Exp. Ther. 297 (2001) 121-127
5. Cossu G., Ledent C., Fattore L., Imperato A., Bohme G.A., Parmentier M., and Fratta W. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav. Brain Res. 118 (2001) 61-65
6. De Vries T.J., Homberg J.R., Binnekade R., Raaso H., and Schoffelmeer A.N. Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology (Berl.) 168 (2003) 164-169
7. De Vries T.J., and Schoffelmeer A.N. Cannabinoid CB1 receptors control conditioned drug seeking. Trends Pharmacol. Sci. 26 (2005) 420-426
8. Di Marzo V., Berrendero F., Bisogno T., Gonzalez S., Cavaliere P., Romero J., Cebeira M., Ramos J.A., and Fernandez-Ruiz J.J. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. J. Neurochem. 74 (2000) 1627-1635
9. Fan F., Tau Q., and Abood Mand Martin B.R. Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res. 706 (1996) 13-20
10. Ghozland S., Matthes H.W., Simonin F., Filliol D., Kieffer B.L., and Maldonado R. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J. Neurosci. 22 (2002) 1146-1154
11. Gonzalez S., Fernandez-Ruiz J., Sparpaglione V., Parolaro D., and Ramos J.A. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend. 66 (2002) 77-84
12. Hoffman A.F., and Lupica C.R. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J. Neurophysiol. 85 (2001) 72-83
13. Hoffman A.F., Oz M., Caulder T., and Lupica C.R. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J. Neurosci. 23 (2003) 4815-4820
14. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiat. 162 (2005) 1403-1413
15. Maldonado R., and Rodriguez de Fonseca F. Cannabinoid addiction: behavioral models and neural correlates. J. Neurosci. 22 (2002) 3326-3331
16. Maldonado R., Valverde O., and Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 29 (2006) 225-232
17. Mansour A., Fox C.A., Thompson R.C., Akil H., and Watson S.J. mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res. 643 (1994) 245-265
18. Manzanares J., Corchero J., Romero J., Fernandez-Ruiz J.J., Ramos J.A., and Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci. 20 (1999) 287-294
19. Martin M., Ledent C., Parmentier M., Maldonado R., and Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur. J. Neurosci. 12 (2000) 4038-4046
20. Moaddab M., Haghparast A., and Hassanpour-Ezatti M. Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat. Behav. Brain Res. (2008)
21. Navarro M., Chowen J., Rocio A.C.M., del Arco I., Villanua M.A., Martin Y., Roberts A.J., Koob G.F., and de Fonseca F.R. CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. Neuroreport 9 (1998) 3397-3402
22. Paxinos G., and Watson C.R. The Rat Brain in Stereotaxic Coordinates (2005), Elsevier Academic Press, San Diego pp. 62-65
23. Peoples L.L. Neuroscience. Will, anterior cingulate cortex, and addiction. Science 296 (2002) 1623-1624
24. Pickel V.M., Chan J., Kash T.L., Rodriguez J.J., and MacKie K. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 127 (2004) 101-112
25. Robbe D., Alonso G., Duchamp F., Bockaert J., and Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21 (2001) 109-116
26. Ronesi J., Gerdeman G.L., and Lovinger D.M. Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J. Neurosci. 24 (2004) 1673-1679
27. Schoffelmeer A.N., Hogenboom F., Wardeh G., and De Vries T.J. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core. Neuropharmacology 51 (2006) 773-781
28. Singh M.E., Verty A.N., McGregor I.S., and Mallet P.E. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Res. 1026 (2004) 244-253
29. Solinas M., Panlilio L.V., Antoniou K., Pappas L.A., and Goldberg S.R. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole -3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats. J. Pharmacol. Exp. Ther. 306 (2003) 93-102
30. Sukhotina I.A. Morphine withdrawal-facilitated aggression is attenuated by morphine-conditioned stimuli. Pharmacol. Biochem. Behav. 68 (2001) 93-98
31. Svingos A.L., Moriwaki A., Wang J.B., Uhl G.R., and Pickel V.M. mu-Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens. J. Neurosci. 17 (1997) 2585-2594
32. Tanda G., Pontieri F.E., and Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276 (1997) 2048-2050
33. Vigano D., Grazia Cascio M., Rubino T., Fezza F., Vaccani A., Di Marzo V., and Parolaro D. Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. Neuropsychopharmacology 28 (2003) 1160-1167
34. Voorn P., Brady L.S., Berendse H.W., and Richfield E.K. Densitometrical analysis of opioid receptor ligand binding in the human striatum. I. Distribution of mu opioid receptor defines shell and core of the ventral striatum. Neuroscience 75 (1996) 777-792